相似文献
1
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.
Cancer Prev Res (Phila). 2023 Jan 4;16(1):47-55. doi: 10.1158/1940-6207.CAPR-22-0210.
2
Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers.
Expert Rev Anticancer Ther. 2018 May;18(5):487-499. doi: 10.1080/14737140.2018.1449648. Epub 2018 Mar 20.
3
Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201).
J Dermatol. 2019 Jul;46(7):557-563. doi: 10.1111/1346-8138.14923. Epub 2019 May 15.
4
Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T-cell lymphoma.
J Dermatol. 2020 May;47(5):443-451. doi: 10.1111/1346-8138.15310. Epub 2020 Mar 18.
5
Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.
Mol Pharmacol. 2012 Feb;81(2):228-38. doi: 10.1124/mol.111.072967. Epub 2011 Nov 3.
6
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
Br J Cancer. 2008 Apr 22;98(8):1380-8. doi: 10.1038/sj.bjc.6604320. Epub 2008 Mar 25.
7
Long-term control of mycosis fungoides of the hands with topical bexarotene: an update 15 years later.
Int J Dermatol. 2019 Nov;58(11):e221-e222. doi: 10.1111/ijd.14555. Epub 2019 Jun 17.
8
Optimized Bexarotene Aerosol Formulation Inhibits Major Subtypes of Lung Cancer in Mice.
Nano Lett. 2019 Apr 10;19(4):2231-2242. doi: 10.1021/acs.nanolett.8b04309. Epub 2019 Mar 21.
9
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.
J Clin Oncol. 2003 Mar 15;21(6):999-1006. doi: 10.1200/JCO.2003.05.068.
10
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
Cancer Prev Res (Phila). 2021 Sep;14(9):851-862. doi: 10.1158/1940-6207.CAPR-20-0496. Epub 2021 Jul 15.
引用本文的文献
1
Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy.
Sci Rep. 2023 Sep 2;13(1):14466. doi: 10.1038/s41598-023-41325-9.
2
Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
Recent Pat Anticancer Drug Discov. 2024;19(5):681-694. doi: 10.2174/1574892819666230831112815.
3
Targeting nuclear hormone receptors for the prevention of breast cancer.
Front Med (Lausanne). 2023 Jul 31;10:1200947. doi: 10.3389/fmed.2023.1200947. eCollection 2023.
本文引用的文献
1
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers.
Cancer Prev Res (Phila). 2019 Dec;12(12):903-912. doi: 10.1158/1940-6207.CAPR-19-0310. Epub 2019 Sep 4.
2
Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.
Cancer Chemother Pharmacol. 2015 Dec;76(6):1235-46. doi: 10.1007/s00280-015-2848-y. Epub 2015 Nov 11.
3
A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045.
4
From carrot to clinic: an overview of the retinoic acid signaling pathway.
Cell Mol Life Sci. 2010 May;67(9):1423-45. doi: 10.1007/s00018-010-0268-z. Epub 2010 Feb 7.
5
Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata.
J Am Acad Dermatol. 2009 Oct;61(4):592.e1-9. doi: 10.1016/j.jaad.2009.02.037. Epub 2009 Aug 14.
6
Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.
Cancer Prev Res (Phila). 2009 Feb;2(2):168-74. doi: 10.1158/1940-6207.CAPR-08-0107. Epub 2009 Jan 27.
7
The Novel Retinoid, 9cUAB30, Inhibits Telomerase and Induces Apoptosis in HL60 Cells.
Transl Oncol. 2008 Sep;1(3):148-52. doi: 10.1593/tlo.08142.
8
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
Br J Cancer. 2008 Apr 22;98(8):1380-8. doi: 10.1038/sj.bjc.6604320. Epub 2008 Mar 25.
9
Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
Carcinogenesis. 2006 Jun;27(6):1232-9. doi: 10.1093/carcin/bgi308. Epub 2005 Dec 12.
10
Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
J Clin Oncol. 2005 May 1;23(13):2980-7. doi: 10.1200/JCO.2005.06.064.
Zotero 插件